Anthony E. Altig's most recent trade in Assembly Biosciences Inc was a trade of 2,750 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 29, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Assembly Biosciences Inc | Anthony E. Altig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 2,750 | 2,750 | - | - | Stock Option (right to buy) | |
Assembly Biosciences Inc | Anthony E. Altig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Assembly Biosciences Inc | Anthony E. Altig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Assembly Biosciences Inc | Anthony E. Altig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
Assembly Biosciences Inc | Anthony E. Altig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |